This metabolite, produced by both cancer cells and Treg cells via CD39 and CD73 enzymes, contributes to tumor development, by negatively regulating the trafficking, proliferation, and functionality of NK cells [105,106,107,108]. The gene discussed is NT5E; the disease is cancer.